ABVC BIOPHARMA, INC. — All Filings
778 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-KT
10-Q
10-Q/A
10KSB
10KSB/A
10QSB
3
3/A
4
4/A
424B1
424B2
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
AW
CERT
CORRESP
D
DEF 14A
DEFA14A
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREM14A
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| POS AM | POST-EFFECTIVE AMENDMENT NO. 5 TO FORM S-1 | 0001213900-26-035543 | Mar 27, 2026 | — |
| 8-K | CURRENT REPORT | 0001213900-26-035499 | Mar 27, 2026 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-26-024122 | Mar 5, 2026 | Mar 26, 2026 |
| 10-K | ANNUAL REPORT | 0001213900-26-023063 | Mar 3, 2026 | Dec 31, 2025 |
| 10-Q/A | AMENDMENT NO. 1 TO FORM 10-Q | 0001213900-26-023062 | Mar 3, 2026 | Sep 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-26-023054 | Mar 3, 2026 | — |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-26-012888 | Feb 5, 2026 | — |
| 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-26-005165 | Jan 16, 2026 | Apr 30, 2025 |
| 424B4 | PROSPECTUS SUPPLEMENT | 0001213900-25-110903 | Nov 14, 2025 | — |
| 424B4 | PROSPECTUS SUPPLEMENT | 0001213900-25-110902 | Nov 14, 2025 | — |
| 424B4 | PROSPECTUS SUPPLEMENT | 0001213900-25-110900 | Nov 14, 2025 | — |
| 424B4 | PROSPECTUS SUPPLEMENT | 0001213900-25-110898 | Nov 14, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-104900 | Nov 3, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-104811 | Nov 3, 2025 | Sep 30, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-103799 | Oct 30, 2025 | Oct 28, 2025 |
| 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-25-086952 | Sep 12, 2025 | Oct 18, 2024 |
| 424B4 | PROSPECTUS SUPPLEMENT | 0001213900-25-077489 | Aug 15, 2025 | — |
| 424B4 | PROSPECTUS SUPPLEMENT | 0001213900-25-077487 | Aug 15, 2025 | — |
| 424B4 | PROSPECTUS SUPPLEMENT | 0001213900-25-077482 | Aug 15, 2025 | — |
| 424B4 | PROSPECTUS SUPPLEMENT | 0001213900-25-077476 | Aug 15, 2025 | — |
| 424B4 | PROSPECTUS SUPPLEMENT | 0001213900-25-077473 | Aug 15, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-076018 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000929638-25-003007 | Aug 13, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-075644 | Aug 13, 2025 | Jun 30, 2025 |
| 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-25-065728 | Jul 18, 2025 | Feb 8, 2024 |
| SCHEDULE 13D/A | — | 0001213900-25-064283 | Jul 15, 2025 | — |
| S-8 | REGISTRATION STATEMENT | 0001213900-25-058995 | Jun 27, 2025 | — |
| 8-K | CURRENT REPORT | 0001213900-25-051144 | Jun 4, 2025 | Jun 3, 2025 |
| SCHEDULE 13D | — | 0001213900-25-050762 | Jun 3, 2025 | — |
| 8-K/A | FORM 8-K/A | 0001213900-25-049491 | May 30, 2025 | Apr 30, 2025 |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 0001213900-25-047480 | May 27, 2025 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 4 TO FORM S-1 | 0001213900-25-047471 | May 27, 2025 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 6 TO FORM S-1 | 0001213900-25-047464 | May 27, 2025 | — |
| S-3 | REGISTRATION STATEMENT | 0001213900-25-046831 | May 22, 2025 | — |
| EFFECT | — | 9999999995-25-001662 | May 20, 2025 | — |
| EFFECT | — | 9999999995-25-001660 | May 20, 2025 | — |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-044910 | May 16, 2025 | Jun 3, 2025 |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 0001213900-25-044891 | May 16, 2025 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 0001213900-25-044880 | May 16, 2025 | — |
| 8-K/A | AMENDMENT TO FORM 8-K | 0001213900-25-043354 | May 14, 2025 | Apr 30, 2025 |
| 8-K/A | AMENDMENT NO. 2 TO FORM 8-K | 0001213900-25-042982 | May 14, 2025 | Jul 12, 2024 |
| 8-K/A | CURRENT REPORT | 0001213900-25-040194 | May 6, 2025 | Apr 30, 2025 |
| 8-K/A | FORM FORM 8-K/A | 0001213900-25-039184 | May 2, 2025 | Apr 15, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-038060 | May 1, 2025 | — |
| 10-Q | QUARTERLY REPORT | 0001213900-25-037676 | Apr 30, 2025 | Mar 31, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-037654 | Apr 30, 2025 | — |
| PRE 14A | PRELIMINARY PROXY STATEMENT | 0001213900-25-035169 | Apr 25, 2025 | Apr 24, 2025 |
| 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 0001213900-25-032468 | Apr 16, 2025 | Apr 15, 2025 |
| 8-K | CURRENT REPORT | 0001213900-25-032135 | Apr 15, 2025 | — |
| 10-K | ANNUAL REPORT | 0001213900-25-032118 | Apr 15, 2025 | Dec 31, 2024 |